Moon, Hyeong Cheol
Park, Sang Joon
Kim, Young Deok
Kim, Kyung Min
Kang, Ho
Lee, Eun Jung
Kim, Min-Sung
Kim, Jin Wook
Kim, Yong Hwy
Park, Chul-Kee
Kim, Young Gyu
Dho, Yun-Sik
Funding for this research was provided by:
Korea Medical Device Development Fund granted by the Korean government (202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08, 202012E08)
Article History
Received: 6 September 2021
Accepted: 7 March 2022
First Online: 16 March 2022
Competing interests
: Sang Joon Park is the founder and CEO of MEDICALIP. Chul-Kee Park and Yun-Sik Dho own stock options in MEDICALIP. Other authors have no conflict of interest to declare.